Parexel saw shares drop 4.3% after releasing information on the embezzlement of corporate funds at one of the company’s international operations in an SEC filing.
Get the full story at our sister site, Medical Design & Outsourcing.
Home » Parexel shares slide on embezzlement news
In case you missed it
- Zimmer Biomet, Align Technology ink distribution deal
- Report: Medtronic plans 100 more layoffs in shift from California to Massachusetts
- Integra Lifesciences touts Cadence ankle study
- Active Implants wins breakthrough nod for NUsurface knee implant
- Key questions for medical device companies to tackle gaps in cybersecurity processes
- Where are the world’s medtech headquarters?
- Tandem Diabetes Care touts real-world t:slim X2 insulin pump data
- FDA clears Viseon’s Voyant spine surgery imaging device
- Covalon closes $6m private placement
- LimFlow wins FDA nod for pDVA trial in chronic limb-threatening ischemia
- Globus acquires StelKast for $28.4m
- The 10 largest medical device companies in the world
- STeP would make treatments for non-life-threatening conditions safer
- Pulmatrix doses first patient in Pulmazole trial
- Dexcom adds COO to CFO Blackford’s title | Personnel Moves, September 19, 2019
- Understanding budgets, extra costs and feasibility in clinical research
- West Virginia AG sues Johnson & Johnson over pelvic mesh
MassDevice Network
@MassDevice
LinkedIn
YouTube
Leave a Reply
You must be logged in to post a comment.